| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |